Cargando…

Synthesis and In Vitro Testing of YVO(4):Eu(3+)@silica-NH-GDA-IgG Bio-Nano Complexes for Labelling MCF-7 Breast Cancer Cells

We present a visual tool and facile method to detect MCF-7 breast cancer cells by using YVO(4):Eu(3+)@silica-NH-GDA-IgG bio-nanocomplexes. To obtain these complexes, YVO(4):Eu(3+) nanoparticles with a uniform size of 10–25 nm have been prepared firstly by the hydrothermal process, followed by surfac...

Descripción completa

Detalles Bibliográficos
Autores principales: Huong, Tran Thu, Vinh, Le Thi, Khuyen, Hoang Thi, Tuyen, Le Dac, Van, Nguyen Duc, Thao, Do Thi, Phuong, Ha Thi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9822125/
https://www.ncbi.nlm.nih.gov/pubmed/36615474
http://dx.doi.org/10.3390/molecules28010280
Descripción
Sumario:We present a visual tool and facile method to detect MCF-7 breast cancer cells by using YVO(4):Eu(3+)@silica-NH-GDA-IgG bio-nanocomplexes. To obtain these complexes, YVO(4):Eu(3+) nanoparticles with a uniform size of 10–25 nm have been prepared firstly by the hydrothermal process, followed by surface functionalization to be bio-compatible and conjugated with cancer cells. The YVO(4):Eu(3+)@silica-NH-GDA-IgG nanoparticles exhibited an enhanced red emission at 618 nm under an excitation wavelength of 355 nm and were strongly coupled with MCF-7 breast cancer cells via biological conjugation. These bio-nanocomplexes showed a superior sensitiveness for MCF-7 cancer cell labelling with a detection percentage as high as 82%, while no HEK-293A healthy cells were probed under the same conditions of in vitro experiments. In addition, the detection percentage of MCF-7 breast cancer cells increased significantly via the functionalization and conjugation of YVO(4):Eu(3+) nanoparticles. The experimental results demonstrated that the YVO(4):Eu(3+)@silica-NH-GDA-IgG bio-nanocomplexes can be used as a promising labelling agent for biomedical imaging and diagnostics.